Comparison between Quick Heal Technologies IPO and Thyrocare Technologies IPO.
Quick Heal Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Quick Heal Technologies IPO is up to ₹451.25 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Quick Heal Technologies IPO is ₹321.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.
| Quick Heal Technologies IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹311.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹321.00 per share | ₹446.00 per share |
| Issue Price (Final) | ₹321.00 per share | ₹446.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 45 shares | 33 shares |
| Fresh Issue Size | 77,88,161 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹250.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 62,69,558 shares | 1,07,44,708 shares |
| OFS Issue Size (Amount) | up to ₹201.25 Cr | up to ₹479.21 Cr |
| Issue Size Total | 1,40,57,719 shares | 1,07,44,708 shares |
| Issue Size Total (Amount) | up to ₹451.25 Cr | up to ₹479.21 Cr |
Quick Heal Technologies IPO opens on Feb 08, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Quick Heal Technologies IPO and Thyrocare Technologies IPO is Feb 10, 2016, and Apr 29, 2016, respectively.
| Quick Heal Technologies IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Feb 05, 2016 | Apr 26, 2016 |
| Issue Open | Feb 08, 2016 | Apr 27, 2016 |
| Issue Close | Feb 10, 2016 | Apr 29, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 18, 2016 | May 09, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Quick Heal Technologies IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .
| Quick Heal Technologies IPO | Thyrocare Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 64.96 | |||||
| Promoter Shareholding (Post-Issue) | 63.96 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2247.96 Cr. | ₹2396.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 17.37 |
In the Quick Heal Technologies IPO Retail Individual Investors (RII) are offered 48,65,685 shares while in Thyrocare Technologies IPO retail investors are offered 48,65,685 shares. Qualified Institutional Buyers (QIB) are offered 27,80,391 shares in Quick Heal Technologies IPO and 21,48,942 shares in Thyrocare Technologies IPO.
| Quick Heal Technologies IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 41,70,586 shares | 32,23,411 shares |
| Market Maker Reservation | ||
| QIB | 27,80,391 shares | 21,48,942 shares |
| NII | 20,85,294 shares | 16,11,707 shares |
| RII | 48,65,685 shares | 37,60,648 shares |
| Employee | 1,55,763 shares | |
| Others | ||
| Total | 1,40,57,719 shares | 1,07,44,708 shares |
Quick Heal Technologies IPO subscribed 10.79x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.
| Quick Heal Technologies IPO | Thyrocare Technologies IPO | |
|---|---|---|
| QIB (times) | 4.34x | 73.18x |
| NII (times) | 36.69x | 225.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.82x | 8.73x |
| Employee (times) | 0.23x | |
| Other (times) | ||
| Total (times) | 10.79x | 73.55x |
